Patent ID: 11951115
Assignee: UNITY BIOTECHNOLOGY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 24:
25. The method of claim 14, wherein the patient demonstrates an improvement in at least 5 ETDRS letter improvement on BCVA over baseline, or at least 6 ETDRS letter improvement on BCVA over baseline, or at least 7 ETDRS letter improvement on BCVA over baseline, or at least 8 ETDRS letter improvement on BCVA over baseline, or at least 9 ETDRS letter improvement on BCVA over baseline, or at least 10 ETDRS letter improvement on BCVA over baseline, at least 15 ETDRS letter improvement on BCVA over baseline, or at least 20 ETDRS letter improvement on BCVA over baseline.